LaurenH Posted January 9, 2018 Share Posted January 9, 2018 If you have been diagnosed with metastatic non-small cell lung cancer (NSCLC), you may be able to participate in a survey study. ICON is a global health research company contracted by pharmaceutical companies to conduct research. ICON is looking for U.S. patients to participate in a survey for people who have been diagnosed with metastatic NSCLC. The purpose of this study is to gain insight into the preferences of patients for treatment. This study consists of a one-time online survey that will take about 30 minutes to complete. Participants will receive $30 if they are eligible and complete the entire survey. If you are interested in participating in this survey, please visit: http://survey.euro.confirmit.com/wix/p1860621515.aspx This survey has been approved for posting by LUNGevity. Quote Link to comment Share on other sites More sharing options...
Recommended Posts